Chevallard Daniel R.
SEC CIK 1706176 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LENZ | LENZ Therapeutics, Inc. | CFO | 12.9K | $164.3K | — | 3 | 2024-05-14 | 2026-03-27 |
Most active insiders at LENZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Versant Vantage II GP-GP, LLC | 10% | — | $10.35M |
| 2 | Olsson Shawn | Chief Commercial Off | — | $261.0K |
| 3 | Schimmelpennink Evert B. | Pres, CEO, Sec, Dir | $251.4K | — |
| 4 | MCCOLLUM JAMES W | Dir | $239.3K | — |
| 5 | Chevallard Daniel R. | CFO | $114.3K | — |
| 6 | George Jeffrey P. | Dir | $49.9K | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-27 | LENZ | LENZ Therapeutics, Inc. | Chevallard Daniel R. | CFO | P - Purchase | $8.57 | +7,500 | 12.9K | +139% | +$64.3K | |
| M | 2025-11-07 | 2025-11-07 | LENZ | LENZ Therapeutics, Inc. | Chevallard Daniel R. | CFO | P - Purchase | $22.76 | +2,198 | 3,208 | +218% | +$50.0K |
| 2024-05-15 | 2024-05-14 | LENZ | LENZ Therapeutics, Inc. | Chevallard Daniel R. | CFO | P - Purchase | $15.68 | +3,188 | 3,188 | New | +$50.0K |
Purchase Sale Sale after option exercise All abbreviations